However, the potent receptor occupation of these agents led to the potential side effects, such as anemia.16 Therefore, it is very urgent to develop CD47 blocking therapeutics which could reduce the potential side effects and maintain a good balance between safety and efficacy. The gene discussed is CD47; the disease is anemia (phenotype).